Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations

Medicine, Oncology, Treatment Planning +14

RECIST 1.1—Update and clarification: From the RECIST committee

Lawrence H. Schwartz, Saskia Litière, Elisabeth G.E. de Vries et al. · European Journal of Cancer · 2016 · 1.9K citations

Agriculture, Public Policy, Separation Of Powers +3

European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update

Börje Ljungberg, Laurence Albigès, Yasmin Abu‐Ghanem et al. · European Urology · 2022 · 1.5K citations · Full text

Medicine, Oncology, Urology +17

Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02

Lester J. Peters, Brian O’Sullivan, J. Giralt et al. · Journal of Clinical Oncology · 2010 · 808 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Renal Function After Nephron-sparing Surgery Versus Radical Nephrectomy: Results from EORTC Randomized Trial 30904

Emil Scosyrev, Edward M. Messing, Richard Sylvester et al. · European Urology · 2013 · 536 citations

Medicine, Surgery, Urology +8